A cost-effectiveness evaluation of imatinib versus interferon-alpha plus low-dose Ara-C for first-line treatment of patients with newly diagnosed chronic myeloid leukemia in the chronic phase.
Reed, SD; Anstrom, KJ; Foster, JA; Glendening, AG; Schulman, KA
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
45th Annual Meeting of the American-Society-of-Hematology
Conference Start Date
Conference End Date